Healthcare
April 25, 2018 / 8:35 AM / 7 months ago

BRIEF-Zhejiang Hisoar Pharmaceutical sees FY 2018 H1 net profit down 10 pct to 60 pct

1 Min Read

April 25 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd

* Says it sees net profit for FY 2018 H1 to decrease by 10 percent to 60 percent, or to be 97.4 million yuan to 219.1 million yuan

* Says the net profit of FY 2017 H1 was 243.5 million yuan

Source text in Chinese:goo.gl/TqQ2oL

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.